SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: DAVID BROWN who wrote (711)3/25/1998 5:13:00 PM
From: marc ultra  Read Replies (2) | Respond to of 9523
 
biz.yahoo.com

Anyone take note of this? This could be a huge drug, an NSAID without GI problems and I wasn't aware Pfizer was getting a piece of this from Monsanto. I know everyone's excited about Viagra but I wonder if any ideas of what this drug might bring them?

Marc



To: DAVID BROWN who wrote (711)3/25/1998 8:32:00 PM
From: Dave  Read Replies (1) | Respond to of 9523
 
Availablility one week after approval seems way too soon. Typically, drug companies can't fill the pipeline until after a formal approval and they still need a launch meeting which would happen after the approval as well. That takes some time to arrange. I'm all for getting the drug out early but a week after approval seems overly optimistic in my humble estimation. Of course, this is only one man's opinion! <g>


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News